These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 1571451)
1. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. Fichtenbaum CJ; Smith MJ Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451 [TBL] [Abstract][Full Text] [Related]
2. Successful use of higher-than-recommended dosage of imipenem in Pseudomonas aeruginosa endocarditis. King JH; Kailath EJ; Hrdy DB Ann Pharmacother; 1992 May; 26(5):639-41. PubMed ID: 1591421 [TBL] [Abstract][Full Text] [Related]
3. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis. Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273 [TBL] [Abstract][Full Text] [Related]
4. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections. Uhari M; Seppänen J; Heikkinen E Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680 [TBL] [Abstract][Full Text] [Related]
5. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Solomkin JS; Dellinger EP; Christou NV; Busuttil RW Ann Surg; 1990 Nov; 212(5):581-91. PubMed ID: 2241313 [TBL] [Abstract][Full Text] [Related]
7. Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics. Navas D; Caillon J; Gras-Le Guen C; Jacqueline C; Kergueris MF; Bugnon D; Potel G J Antimicrob Chemother; 2004 Oct; 54(4):767-71. PubMed ID: 15317741 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes. Yadav R; Bulitta JB; Wang J; Nation RL; Landersdorfer CB Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993331 [TBL] [Abstract][Full Text] [Related]
10. Treatment of nosocomial infections in children undergoing antimicrobial chemotherapy. Bonatti H; Guggenbichler JP; Hager J Infection; 1990; 18(5):302-6. PubMed ID: 2276826 [TBL] [Abstract][Full Text] [Related]
11. Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008. Reyes MP; Ali A; Mendes RE; Biedenbach DJ Medicine (Baltimore); 2009 Sep; 88(5):294-301. PubMed ID: 19745688 [TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection. Erasmo AA; Crisostomo AC; Yan LN; Hong YS; Lee KU; Lo CM Asian J Surg; 2004 Jul; 27(3):227-35. PubMed ID: 15564167 [TBL] [Abstract][Full Text] [Related]
13. Use of imipenem-cilastatin in pediatrics. Overturf GD Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788 [No Abstract] [Full Text] [Related]
14. Imipenem/cilastatin treatment of bacterial meningitis in children. Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603 [TBL] [Abstract][Full Text] [Related]
15. [Right endocarditis caused by Pseudomonas aeruginosa in a heroin addict: cure with medical treatment]. Sánchez A; González M; Iñigo MA; Rojas E; Acosta M Enferm Infecc Microbiol Clin; 1991 May; 9(5):314-5. PubMed ID: 1954270 [No Abstract] [Full Text] [Related]
16. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Fink MP; Snydman DR; Niederman MS; Leeper KV; Johnson RH; Heard SO; Wunderink RG; Caldwell JW; Schentag JJ; Siami GA Antimicrob Agents Chemother; 1994 Mar; 38(3):547-57. PubMed ID: 8203853 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests. Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302 [TBL] [Abstract][Full Text] [Related]
18. Non-nosocomial healthcare-associated left-sided Pseudomonas aeruginosa endocarditis: a case report and literature review. Hagiya H; Tanaka T; Takimoto K; Yoshida H; Yamamoto N; Akeda Y; Tomono K BMC Infect Dis; 2016 Aug; 16(1):431. PubMed ID: 27543116 [TBL] [Abstract][Full Text] [Related]
19. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus. Asensi F; Pérez-Tamarit D; Otero MC; Gallego M; Llanes S; Abadia C; Cantó E Pediatr Infect Dis J; 1989 Dec; 8(12):895. PubMed ID: 2626294 [No Abstract] [Full Text] [Related]
20. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa]. Yamashiro Y; Ogake N; Takahata M; Minami S Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]